These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3763648)

  • 1. The study of the precorneal dynamics of ophthalmic solutions by fluorophotometry.
    Ludwig A; Van Ooteghem M
    Pharm Acta Helv; 1986; 61(8):236-40. PubMed ID: 3763648
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of the osmolality on the precorneal retention of ophthalmic solutions.
    Ludwig A; Van Ooteghem M
    J Pharm Belg; 1987; 42(4):259-66. PubMed ID: 3694417
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between precorneal retention of viscous eye drops and tear fluid composition.
    Ludwig A; van Haeringen NJ; Bodelier VM; Van Ooteghem M
    Int Ophthalmol; 1992 Jan; 16(1):23-6. PubMed ID: 1537645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ophthalmic vehicles using fluorescein uptake technique.
    Capella JA; Schaefer IM
    Eye Ear Nose Throat Mon; 1974 Jan; 53(1):23-5. PubMed ID: 4208067
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of intracanalicular collagen implants on the absorption of topically applied sodium fluorescein.
    Unterman SR; Reidy JJ; Hill JH; Kaufman HE
    Cornea; 1991 Nov; 10(6):516-8. PubMed ID: 1782780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hydrophilic contact lenses to increase ocular penetration of topical drugs.
    Waltman SR; Kaufman HE
    Invest Ophthalmol; 1970 Apr; 9(4):250-5. PubMed ID: 5435768
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of the dropsize on the elimination of an ophthalmic solution from the precorneal area of human eyes.
    Ludwig A; Van Ooteghem M
    Pharm Acta Helv; 1987; 62(2):56-60. PubMed ID: 3575342
    [No Abstract]   [Full Text] [Related]  

  • 8. [Objective indices of corneal transparency and of fluorescein permeability through the cornea before and after photorefractive keratectomy].
    Polunin GS; Kurenkov VV; Makarov IA; Polunina EG
    Vestn Oftalmol; 1998; 114(5):19-21. PubMed ID: 9865178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial permeability of the living cornea to fluorescein.
    Ota Y; Mishima S; Maurice DM
    Invest Ophthalmol; 1974 Dec; 13(12):945-9. PubMed ID: 4430576
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological availability of ophthalmic drugs. 1. Increasing drug permeability in the cornea].
    Masteiková R; Chalupová Z; Savickiene N
    Ceska Slov Farm; 2004 Mar; 53(2):73-9. PubMed ID: 15095575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the surface tension of eye drops on the retention of a tracer in the precorneal area of human eyes.
    Ludwig A; Van Ooteghem M
    J Pharm Belg; 1988; 43(3):157-62. PubMed ID: 3171869
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of hydroxypropylmethylcellulose on corneal contact times of ophthalmic solution (author's transl)].
    Kitazawa Y; Takahashi O; Matsumoto T; Iinuma T; Tateno Y
    Nippon Ganka Gakkai Zasshi; 1977 Sep; 81(9):1509-14. PubMed ID: 605880
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypotony and aqueous humor dynamics in myotonic dystrophy.
    Walker SD; Brubaker RF; Nagataki S
    Invest Ophthalmol Vis Sci; 1982 Jun; 22(6):744-51. PubMed ID: 7076420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of fluorometry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle: comparison with scintigraphy.
    Maurice DM; Srinivas SP
    J Pharm Sci; 1992 Jul; 81(7):615-9. PubMed ID: 1403690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid.
    Mochizuki H; Yamada M; Hato S; Nishida T
    Br J Ophthalmol; 2008 Jan; 92(1):108-11. PubMed ID: 18156377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A fluorescein-containing anesthetic eyewash for aplanation tonometry].
    Heitz R
    Bull Soc Ophtalmol Fr; 1967; 67(7):536-7. PubMed ID: 5598073
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of tear substitutes and their immediate effect on the precorneal tear film.
    Avisar R; Creter D; Levinsky H; Savir H
    Isr J Med Sci; 1997 Mar; 33(3):194-7. PubMed ID: 9313790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cornea preparation for in vitro bio-pharmaceutical evaluation of ophthalmic dosage forms.
    Barrelet J; Tsacopoulos M; Buri P
    J Pharm Pharmacol; 1975 Dec; 27(12):919-22. PubMed ID: 2663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age on the penetration of fluorescein into the human eye.
    Nzekwe EU; Maurice DM
    J Ocul Pharmacol; 1994; 10(3):521-3. PubMed ID: 7836860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The bioavailability of eye drops].
    Andermann G; Andermann C; Mergel D
    Pharm Acta Helv; 1978; 53(9-10):291-300. PubMed ID: 740715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.